In this issue:
Valproate and retinoic acid + decitabine in AML
New prognostic score for DLBCL
Treatment-free remission after first-line dasatinib discontinuation
Polatuzumab vedotin in R/R DLBCL
Ivosidenib induces deep durable remissions in AML
Long-term follow-up of nodular lymphocyte-predominant Hodgkin lymphoma
Treatment of older patients with MCL
Optimising CAR T-cell therapy in ALL
CAR-transduced natural killer cells
Acetazolamide as an adjunct to high dose methotrexate
Please login below to download this issue (PDF)